Swedish Orphan Biovitrum, often called Sobi, is a pharmaceutical company based in Stockholm, Sweden. It develops and supplies medicines for rare diseases, concentrating on haematology, immunology and specialty care. Its products include enzyme replacement therapies and treatments for bleeding disorders and other rare conditions. The company serves patients, hospitals and healthcare professionals through its own operations and partners in markets across Europe, North America and other regions of the world.
On this site Swedish Orphan Biovitrum AB (publ) appears as a stock on the Nasdaq Stockholm (Sweden), code SOBI, with prices in Swedish kronor (SEK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Strong price profile
Ranks #16 of 912 on the Nasdaq Stockholm · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Sweden yet.
TrendStrong
81/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average9.3%
From 52-week high-3.3%
MomentumStrong
75/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return0.0%
6-month return16.4%
12-month, skipping last month34.6%
Stability (higher is calmer)Strong
91/100
Calmer than most: low volatility and shallow drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)27.3%
Worst drawdown, 1 year (smaller is calmer)-14.6%
LiquidityStrong
95/100
Trades actively.
See the numbers →
Avg daily value traded128.47M SEK
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Sweden when fundamentals data for this market is added. All Sweden stocks.
52-wk range 314.40 – 487.00Daily closes, split-adjusted
Signals
50-day average445.96
200-day average424.63
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)11.72
Technical summary
Daily
Strongly bullish
12 bullish · 3 neutral · 1 bearish
Weekly
Strongly bullish
11 bullish · 1 neutral · 0 bearish
Monthly
Strongly bullish
7 bullish · 0 neutral · 1 bearish
Moving averages (daily)
SMA 10
448.6
Bullish
EMA 10
450.5
Bullish
SMA 20
439.4
Bullish
EMA 20
445.2
Bullish
SMA 50
446.0
Bullish
EMA 50
444.9
Bullish
SMA 100
451.6
Bullish
EMA 100
441.4
Bullish
SMA 200
424.6
Bullish
EMA 200
420.3
Bullish
Oscillators (daily)
RSI (14)
63.50
Neutral
MACD (12, 26)
4.40
Bullish
Momentum (12)
8.31
Bullish
Stochastic %K (14)
75.69
Neutral
Williams %R (14)
-24.31
Neutral
CCI (20)
187.9
Bearish
Pivot points (classic, last session)
S3
424.0
S2
437.6
S1
450.8
Pivot
464.4
R1
477.6
R2
491.2
R3
504.4
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in SEK. Educational only, not financial advice.
